BMJ's Coronavirus (COVID-19) playlist

BMJ's Coronavirus (COVID-19) playlist

By BMJ GroupMedicine
Download on the App Store

BMJ's Coronavirus (COVID-19) playlist episodes

  • Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases
    In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies.
    Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future.
    Related content:
    https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272

    https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597

    21 min
  • COVID-19: Vaccine immunogenicity, interleukin-6 inhibitors, mucormycosis
    Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to Covid-19.
    Abigail Davis, GP and section editor, covers the latest evidence around vaccine immunogenicity in different immunosuppressed populations, as well as the use of interleukin-6 inhibitors in COVID-19 patients.
    And Emma Scott, section editor, updates us on mucormycosis, or black fungus infection in COVID-19 patients.
    For more, see:
    BMJ Best Practice's topic on COVID-19: bestpractice.bmj.com/topics/en-gb/3000168
    BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): new-learning.bmj.com/course/10065100
    BMJ Learning COVID-19 in primary care module: new-learning.bmj.com/course/10065230
    Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00676-0/fulltext
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2100433
    WHO Therapeutics and COVID-19: living guideline: https://app.magicapp.org/#/guideline/nBkO1E/section/LrV7OL

    Indian Council of Medical Research advice on mucormycosis: https://www.icmr.gov.in/pdf/covid/techdoc/Mucormycosis_ADVISORY_FROM_ICMR_In_COVID19_time.pdf

    13 min
  • Going Medieval: Historical Comparisons of Plague and Pandemic
    Medical Humanities' Editor-in-Chief, Brandy Schillace, talks to Dr. Eleanor Janega, a medieval historian, about comparisons between COVID-19 and the Black Death.

    Read the blog post, which includes the transcript of the podcast, here: https://blogs.bmj.com/medical-humanities/2021/07/15/going-medieval-historical-comparisons-of-plague-and-pandemic/

    28 min
  • COVID - 19 Vaccination and risk of large vessel arterial stroke
    The Oxford Astra Zeneca vaccine has been associated with a rare complication of cerebral venous sinus thrombosis. Dr Colin Mahoney, JNNP Podcast Editor, interviews Prof David Werring, Professor of Clinical Neurology, UCL Queen Square Institute of Neurology, UK, about the new evidence which supports an association between vaccination and more common large vessel arterial stroke. They also discuss several cases, including treatment, and emerging biological evidence relating to causation.
    Read the paper "Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia", on the JNNP website: https://jnnp.bmj.com/content/early/2021/05/20/jnnp-2021-326984.

    Related editorial paper: https://jnnp.bmj.com/content/early/2021/05/20/jnnp-2021-327057

    14 min
  • June 2021 - COVID-19 vaccination in pregnancy
    In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) review the June issue of DTB.
    The list of articles mentioned in this podcast:
    The Editorial “COVID-19 vaccination in pregnancy” - https://dtb.bmj.com/content/59/6/82
    DTB select “Stepping down asthma treatment” - https://dtb.bmj.com/content/59/6/85
    Review “Prescribing for pregnancy: managing diabetes” - https://dtb.bmj.com/content/59/6/88
    Republished case report “Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin)” - https://dtb.bmj.com/content/59/6/93

    Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.

    26 min
  • Covid-19: Vaccination in pregnancy, myocardial infarction, and respiratory conditions
    Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19.
    Emma Scott, section editor, updates us on vaccination for pregnant and breastfeeding women.
    And Abigail Davis, GP and section editor, covers myocardial infarction and pre-existing respiratory conditions.
    For more, see:
    BMJ Best Practice's topic on covid-19: bestpractice.bmj.com/topics/en-gb/3000168
    BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): new-learning.bmj.com/course/10065100

    BMJ Learning covid-19 in primary care module: new-learning.bmj.com/course/10065230

    10 min
  • Effect of IBD medications on COVID-19 outcomes
    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Ryan Ungaro, who is an Assistant Professor at Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA. The podcast is focussed on ‘Effect of IBD medications on COVID-19 outcomes: results from an international registry’ published in paper copy in Gut in April 2021.

    Related or relevant article: https://gut.bmj.com/content/70/4/725

    14 min
  • Generation Covid: Education, Access, and the Long Shadow of Pandemic Trauma
    David Perry is a freelance journalist covering politics, history, education, and disability rights with bylines at CNN, NYT, Atlantic, Guardian and many more. He and his food-scientist wife live in the Twin Cities with their children, one of whom has Down syndrome, and Perry also plays in an Irish rock band.
    Today on the podcast, David talks about access and education under COVID-19. What does it mean to really provide free and fair education to all?
    Read the related blog post, which includes the transcript of this podcast:

    https://blogs.bmj.com/medical-humanities/2021/05/12/generation-covid-education-access-and-the-long-shadow-of-pandemic-trauma

    20 min
  • CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab
    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Tariq Ahmad and Dr Nick Kennedy, both from the Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, UK.
    This special Gut podcast is focused on ‘Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab’ which is published in paper copy in Gut in May 2021 and the recently published paper ‘Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines’.
    Acknowledgements: The CLARITY IBD team would like to thank the CLARITY IBD team in Exeter, all of the 92 CLARITY IBD sites and over 7000 participants in the study. We are grateful to support from the NIHR CRN, Crohn's & Colitis UK and our funders.
    The related links:
    https://gut.bmj.com/content/early/2021/04/25/gutjnl-2021-324789

    https://gut.bmj.com/content/70/5/865

    20 min
  • COVID-19 Vaccine and People who live with HIV
    Thousands of people are currently being vaccinated against COVID-19 worldwide. In this podcast, we discuss if the authorised vaccines are useful to people who live with HIV.
    STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; Dr Laura Waters, Sexual Health and HIV specialist at The Mortimer Market Centre, London, and chair of BHIVA; and Mr Simon Collins, HIV patient advocate and editor of the HIV Treatment Bulletin at the i-Base.
    Read the related blog post: https://blogs.bmj.com/sti/2021/04/23/2021episode3/

    Related article: https://www.bhiva.org/SARS-CoV-2-vaccine-advice-for-adults-living-with-HIV-plain-english-version-update

    25 min

About BMJ's Coronavirus (COVID-19) playlist

From the publisher's feed

Bringing you a curated selection of podcasts relating to COVID-19 across The BMJ, our specialist journals and Best Practice.